EIC Fund completed the investment in SentryX.

Synopsis

EIC Fund, a venture investment arm of the European Innovation Council, completed the investment in SentryX, a clinical stage biopharmaceutical company developing non-opioid therapeutics for the treatment of acute pain after surgery. Financial terms were not disclosed.

Principals

target

SENTRYX

bidder

European Innovation Council Fund

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

bas oosterman

Co-Founder and CEO at SENTRYX

Manager

target

Deal

n/a

Total Value

jorrit-jan verlaan

Co-Founder and Chief Medical Officer at SENTRYX

Manager

target

Deal

n/a

Total Value

Bidder Team (2)

svetoslava georgieva

Chair at EUROPEAN INNOVATION COUNCIL FUND

Investor

bidder

Deals

£ 42 M

Total Value

tom van wijngaarden

Partner at Eversheds Sutherland

Lawyer

bidder

Deals

£ 37 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy